Does the Medline mega-deal herald the return of giant buyouts?

0

Private-equity firms are neck-deep in dry powder


Listen to this story

Your browser does not support the element.

Enjoy more audio and podcasts on iOS or Android.

BUYOUT SHOPS are neck-deep in dry powder. Earlier this year the world’s private-equity firms were sitting on $1.9trn in unspent capital. This month three of the biggest, Blackstone, Carlyle and Hellman & Friedman, reportedly agreed to pay $34bn for control of Medline, a supplier of medical equipment. It will be the biggest leveraged buyout since the global financial crisis of 2007-09 put paid to most such debt-fuelled acquisitions.

This article appeared in the Business section of the print edition under the headline “Dealing with abundance”

Read More

You might also like
Leave A Reply

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More